期刊文献+

构建重组人SERCA2a基因9型腺相关病毒载体和病毒包装

Building of recombinant human SERCA2a gene-mediated 9 adenovirus-associated virus vector and virus packaging
下载PDF
导出
摘要 目的探讨构建重组人SERCA2a基因9型腺相关病毒载体和病毒包装的方法,并包装出rAAV9-hSERCA2a-EGFP。方法根据细菌内同源重组的方法使用腺相关病毒包装系统,将hSERCA2a基因克隆到腺相关病毒载体中,与腺相关病毒包装质粒pAAV pHelper发生重组,通过脂质体共转染人胚肾293(HEK293)细胞,产生重组腺相关病毒,通过酶切鉴定和DNA测序鉴定正确后进行扩增、纯化和滴度测定(采用荧光滴度检测法)。结果酶切鉴定和DNA测序证明重组腺相关病毒载体rAAV9-hSERCA2a-EGFP构建成功,PCR鉴定可见到阳性扩增条带,rAAV9-hSERCA2a-EGFP滴度高达1×1012 vg(virus genomes,vg)/mL。结论本方法成功构建和包装滴度为1×1012 vg/mL携带hSERCA2a基因的rAAV9-hSERCA2a-EGFP。 Objective To explore the way of constructing a recombinant adeno-associated virus vector carry ing the hSERCA2a gene, and to package rAAV9-hSERCA2a-EGFP successfully. Methods According to the method of homologous recombination in bacteria, we used the adeno-associated virus packaging sys terns, we cloned the hSERCA2a gene into the adeno-associated virus vector in recombination with adeno-associated virus packaging plasmid pAAV pHelper. Liposomes were co-transfected into HEK293 cells so as to produce the recombinant adeno-associated virus. After correct identification by restriction endonucle ase digestion and DNA sequencing, amplification, purification and titer determination were detected using the method of fluorescence titer test. Results The results of restriction endonuclease digestion and DNA sequencing showed that recombinant adeno-associated virus vector rAAV9-hSERCA2a-EGFP was con structed successfully; the positive amplification bands could be seen in PCR analysis, and the titer of rAAV9-hSERCA2a-EGFP was determined to be up to 1× 10^12 vg/mL. Conclusion The aging of rAAVg-hSERCA2a-EGFP carrying the hSERCA2a gene is successful at a titer of 1× 10^12 vg/mL.
出处 《新疆医科大学学报》 CAS 2012年第12期1605-1609,共5页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区科技计划项目(201010105)
关键词 肌浆网钙ATP酶 重组腺相关病毒 包装 sarcoplasmic reticulum Ca2+ ATPase adeno-associated virus packaging
  • 相关文献

参考文献13

  • 1陈礼斌,宫海滨.SERCA2a基因转导治疗心力衰竭的研究进展[J].东南大学学报(医学版),2010,29(6):691-694. 被引量:6
  • 2Williams PD, Ranjzad P, Kakar SJ, et al. Development of viral vectors for use in cardiovascular gene therapy[J].Viruses, 2010, 2(2):334-371.
  • 3Carter BJ. Adeno-assoeiated virus vectors in clinical trials[J]. Hum Gene Ther, 2005, 16(5):541-550.
  • 4Ly H, Kawase Y. Yoneyama R, et al. Gene therapy in the treatment of heart failure[J]. Physiology (Bethesda), 2007,22 (2):81-96.
  • 5Xu YJ, Chepman D, Dixon IM, et al. Differential gene expression in infarct scar and viable myocardium from rat heart following coronary ligation[J]. J Cell Mol Med, 2004,8( 1 ) : 83-92.
  • 6del Monte F, Hajjar RJ, Harding SE. Overwhehning evidence of the beneficial effects of SERCA gene transfer in heart failure [J]. CircRes,2001,88(11):E66-E67.
  • 7Gheorghiade M, Ambrosy AP, Ferrandi M, et al. Combining SERCA2a activation and Na K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output [J]. Discovery Medicine, 2011, 12 (63): 141-151.
  • 8Lipskaia L, Chernaly ER, Hadri L, et al. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure [J]. Expert Opin Biol Ther, 2010,10(1):29-41.
  • 9Hajjar RJ, Zsebo K, Deckelbaum L, et al. Design of a phase 1/2 trial of intracoronary administration of AAV 1/SERCA2a inpatients with heart failure[J]. J Card Fail, 2008,14 ( 5 ): 355- 367.
  • 10Cortin V, Thibault J, Jacob D, et al. High-titer adenovirus vector production in 293 cell perfusion culture[J]. Biotechnol Prog, 2004, 20(3):858-863.

二级参考文献27

  • 1惠海鹏,李小鹰,刘秀华,孙胜,鲁晓春,刘涛,杨伟.腺相关病毒介导心肌肌浆网Ca^(2+)-ATPase2a基因转导治疗大鼠慢性心力衰竭[J].中华心血管病杂志,2006,34(4):357-362. 被引量:22
  • 2LYTTON J,ZARAIN-HERZBERG A,PERIASAMY M,et al.Molecular cloning of the mammalian smooth muscle sarco(endo)plasmic reticulum Ca2+ ATPase[J].J Biol Chem,1989,264(4):7059-7065.
  • 3BURK S E,LYTTON J,MacLENNAN D H,et al.cDNA cloning,functional expression and mRNA tissue distribution of a third organellar Ca2+ pump[J].J Biol Chem,1989,264(11):18561-18568.
  • 4FENG B.Structure,function and regulation of the sarcopplasmic reticulum Ca2+ ATPase[J].Pathophysiol Clin Med,1998,18(2):120-123.
  • 5ARAI M,YOGUCHI A,TAKIZAWA T,et al.Mechanism of doxornhicin induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription[J].Circ Res,2000,86(1):8-14.
  • 6WU K D,LEE W S,WEY J,et al.Localization and quantification of endoplasmic reticulum Ca2+ ATPase isoforms transcripts[J].Am J Physiol,1995,269(38):C775-C784.
  • 7HASENFUSS G,PIESKE B.Calcium cycling in congestive heart failure[J].J Mol Cell Cardiol,2002,34(8):951-969.
  • 8TADA M.Calcium cycling proteins of the cardiac sarcoplasmic reticulum[J].Circ J,2003,67(9):729-737.
  • 9NIGGLI E.The cardiac sarcoplasmic reticulum[J].Circ Res,2007,100(5):5-6.
  • 10LI X Y.Research of gene transfer of SERCA2a for failing hearts[J].Chin J Cardiol,2005,6(33):576-578.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部